Oncostellae Developing safer, GI-targeted treatments in IBD and Colorectal cancer Therapeutics Development, market readiness, clinical trial Spain Status Approved IP...
Therapeutics
ENDOLIPID THERAPEUTICS NASH and Cellulite innovative therapies. Therapeutics Development, market readiness, clinical trial España 500.000€ Status Approved IP Type...
Kintsugi Therapeutics Kintsugi Therapeutics is a preclinical-stage biotechcompany developing a first-in-class treatment for NASH. Biotech Prototyping, preclinical Spain 1.000.000€...
AntalGenics, S.L. Innovative Sensory Neurobiology Biotech Prototyping, preclinical Spain 800.000€ Status Approved IP Type Patent Time 16 years Countries Australia...
Gencyte Therapeutics, Inc. Developing next generation of CAR-T platform for cancer treatment. Therapeutics Discovery, Idea USA 1.000.000€ IP Type Status...
PlusVitech Effective treatment by reprofiling an existing drug to save lives from COVID-19 lung damage Therapeutics Development, market readiness, clinical...
aptaTargets aptaTargets innovates through aptamer technology Therapeutics Development, market readiness, clinical trial Spain 1.930.000€ You can visit their website or...
Glycon Pharma Dopamine glycoconjugate that traverses the blood-brain barrier. And more... Therapeutics Prototyping, preclinical USA 1.500.000$ You can visit their...
Limnopharma Novel treatments for disabling ophthalmic diseases Therapeutics In vitro, proof of concept Spain 500.000€ You can visit their website...
